WegovySan Francisco, CA

Wegovy in San Francisco, CA

For San Francisco, California residents, geographic distance from mainland pharmacies has historically affected access to specialty medications. Wegovy® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk; Pacific-region retail pricing varies by pharmacy. Weight Method offers a separate telehealth program: licensed California providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program is priced at $199/month uniformly, shipped directly to your San Francisco address.

FDA-approved Wegovy prescribed by licensed providers. Delivered to your door.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · San Francisco is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated May 2026Medically reviewed by licensed providers

Wegovy in San Francisco, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Wegovy to patients in San Francisco from $199/month with virtual consultations and direct-to-door shipping.

How does this medication work for weight loss?

Semaglutide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Novo Nordisk developed Wegovy® as the FDA-approved Injectable pen product, taken Once weekly, approved in 2021. Weight Method is a separate program: licensed providers in California evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program for eligible San Francisco, CA residents starts at $199/month.

What treatment options are available locally?

In a diverse metropolitan area like San Francisco, healthcare must meet patients where they are — linguistically and culturally. Weight Method prescribes compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy, with full bilingual support in English and Spanish. Compounded Semaglutide is not FDA-approved. Every patient understands their treatment plan, dosing schedule, and what to expect — this is core to how we deliver care in multicultural metros.

Ready to Get Started?

Answer a few quick questions to see if you qualify.

Check Eligibility

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

The most common side effects of Semaglutide are gastrointestinal — mild nausea, decreased appetite, and occasional digestive discomfort. These typically occur during the first few weeks or after dose increases and diminish as your body adjusts. Your Weight Method provider follows a gradual dose-escalation protocol designed to reduce side effects and will monitor your progress throughout treatment. Discuss your full medical history with your provider before starting any GLP-1 therapy.

No. Weight Method operates on a direct-pay model with transparent pricing. The compounded Semaglutide program starts at $199/month and covers your medication, provider consultations, and free delivery to San Francisco. No insurance claims, no prior authorizations, and no surprise bills. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.

Wegovy® is a Injectable pen manufactured by Novo Nordisk, FDA-approved since 2021 for Chronic weight management. It contains Semaglutide, which mimics natural incretin hormones to reduce appetite, slow gastric emptying, and help your body regulate hunger. Wegovy® is taken Once weekly. Weight Method does not sell Wegovy®; we are a separate program that prescribes compounded Semaglutide (dispensed by a U.S.-licensed 503A pharmacy and not FDA-approved) starting at $199/month.

Yes. Weight Method's licensed providers in California can prescribe compounded Semaglutide through a fully virtual process. You complete an online health assessment, have a virtual consultation, and if approved, your compounded Semaglutide is shipped directly to your San Francisco address. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved. There is no need to visit a physical clinic, and the program starts at $199/month.

Wegovy® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk. Weight Method prescribes compounded Semaglutide, which is prepared by a U.S.-licensed 503A compounding pharmacy under state and federal pharmacy regulations. Compounded Semaglutide is not FDA-approved and is a different regulatory category from FDA-approved finished drug products. Your Weight Method provider will discuss whether compounded Semaglutide is an appropriate option based on your medical history.

Start Your Treatment

Consult with a licensed provider in California and start Wegovy from $199/month.

Get Started Now

Free consultation. No commitment.

Other Brands in San Francisco

Ozempic in San FranciscoMounjaro in San FranciscoZepbound in San FranciscoRybelsus in San FranciscoSemaglutide in San Francisco

Nearby Cities

Wegovy in Daly City, CAWegovy in South San Francisco, CAWegovy in Emeryville, CAWegovy in Alameda, CA

See More

All About WegovySemaglutide in San FranciscoClinics in San Francisco